CClinicalTrials.gg
RecruitingNCT07170514TITRANTUpdated Apr 14, 2026

EIT vs Dynamic Compliance Guided PEEP Titration During Laparoscopic Gynecological Surgery

An interventional study of EIT-guided PEEP titration and Cdyn-guided PEEP titration in Mechanical Power, Postoperative Pulmonary Complications (PPCs) and Oxygenation, sponsored by Pest County Flór Ferenc Hospital. Recruiting at 3 sites in Hungary. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by Pest County Flór Ferenc Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this randomized controlled clinical trial is to compare the pulmonary protective effects of two different positive end-expiratory pressure (PEEP) titrating methods in patients with non-injured lungs undergoing laparoscopic gynecological surgery.

Despite dynamic pulmonary compliance (Cdyn) guided lung protective ventilation has several proven advantages, the investigators hypothesize that optimizing intraoperative mechanical ventilation using electrical impedance tomography (EIT) may further improve patient outcomes, enhance postoperative recovery, shorten in-hospital stay and reduce healthcare related costs.

The main questions aim to answer are:

  • May EIT-guided PEEP titration reduce the mechanical power of ventilation and improve oxygenation more significantly than the Cdyn-guided method?
  • What effect might a decrease in mechanical power of ventilation have on postoperative pulmonary complications?

Participants will:

  • Receive an EIT-guided or a Cdyn-guided PEEP titration procedure during laparoscopic gynecological surgery.
  • Be assessed for mechanical power of ventilation, oxygenation, atelectasis and postoperative pulmonary complications during and 2 days after surgery.
  • Be followed-up for mortality until the 28th postoperative day.
Read the detailed description

The aim of this study is to compare the effects of two different - electrical impedance tomography guided (EIT) versus dynamic pulmonary compliance guided (Cdyn) - positive end-expiratory pressure (PEEP) titrating methods on mechanical power of ventilation (MP), oxygenation, respiratory mechanics parameters, global inhomogeneity index (GI), overdistension/collapse (ODCL) and postoperative pulmonary complications (PPCs) in patients with non-injured lungs undergoing laparoscopic gynecological surgery. Despite Cdyn-directed lung protective ventilation has several proven advantages, the investigators hypothesize that optimizing intraoperative mechanical ventilation using EIT may further improve patient outcomes by reducing MP responsible for ventilator induced lung injury (VILI) and consequent PPCs. These anticipated advantages may improve the knowledge about individualized intraoperative protective ventilation, enhance postoperative recovery, shorten in-hospital stay and reduce healthcare related costs.

A total number of 200 patients scheduled for laparoscopic gynecological surgery will be enrolled in this study. An equal number of patients will be randomized into the PEEP-EIT and PEEP-Cdyn groups.

Patients randomized into the PEEP-EIT group receive a decremental PEEP titration procedure directed by EIT PEEP Trial of the Dräger PulmoVista 500 device in order to determine the individually optimal level of PEEP (PEEPopt). Patients in the PEEP-Cdyn Group will undergo the same decremental PEEP titration procedure directed by Cdyn measured by the ventilator of the anesthesia workstation.

During the PEEP titration procedure PEEP will be decreased from 18 cmH2O by 2 cmH2O every 20 ventilatory cycles, until a final PEEP of 6 cmH2O. On each level of PEEP Cdyn values will be recorded. In the PEEP-EIT Group PEEPopt is considered as the intersect between the lower percentage of overdistension and collapse, based on the diagnostic tool of the EIT device. In the PEEP-Cdyn Group optimal PEEP is considered as the PEEP value resulting the highest possible Cdyn measured by the ventilator After the titration procedure, a lung protective mechanical ventilation (LPV) will be performed using PEEPopt and low tidal volumes (TV=6 mL/kg, Ideal Body Weight) in both groups.

Mechanical Power, driving pressure, Cdyn, tidal volume in region of interest 3 and 4 (TVROI3, TVROI4) and end-expiratory lung volumes will be recorded immediately after the PEEP titration trial and every 15 minutes during surgery in both groups.

Oxygenation and dead space fraction indicated by the ratio of arterial oxygen partial pressure to fraction of inspired oxygen (PaO2/FiO2) and arterial to end-tidal carbon dioxide difference, respectively, will be recorded every 30 minutes during surgery in both groups. PaO2/FiO2 ratio will be recorded immediately after extubation and 30 mins, 2, 6, 12, 24 and 48 hours after surgery also.

GI and ODCL will be evaluated retrospectively after surgery using the EIT Diag SW 1.6 diagnostic software for Dräger PulmoVista 500.

During the first and second postoperative days EIT measurements will be performed for atelectasis, while arterial blood gas samples will be assessed to screen gas exchange parameters and laboratory examinations will be performed for Sequential Organ Failure Assessment (SOFA) Scores indicating patients' postoperative clinical conditions.

A follow-up period will be performed for mortality until the 28th day after surgery.

02

Conditions studied

  • Mechanical Power
  • Postoperative Pulmonary Complications (PPCs)
  • Oxygenation

Keywords

  • electrical impedance tomography
  • dynamic pulmonary compliance
  • positive end-expiratory pressure
  • mechanical power
  • pulmonary protective ventilation
  • Pao/FiO2
  • postoperative pulmonary complications
03

In context

Lead sponsor

Pest County Flór Ferenc Hospital is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patient scheduled for elective laparoscopic gynaecological surgery
  • Age > 18 years
  • Signed consent to participate in the trial

Exclusion criteria

Exclusion criteria:

  • Age \< 18 years
  • American Society of Anesthesiologists (ASA) physical status IV
  • History of severe restrictive or chronic obstructive pulmonary disease (COPD, Global Initiative for Chronic Obstructive Lung Disease grades III or IV)
  • Uncontrolled bronchial asthma
  • Pulmonary metastases
  • History of any thoracic surgery
  • Need for thoracic drainage before surgery
  • Congestive heart failure (NYHA grades III or IV)
  • Extreme obesity (BMI>35 kg m-2)
  • Lack of patient's consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    EIT-GROUP

    EIT-guided PEEP titration procedure to achieve individually optimal level of PEEP

    Procedure: EIT-guided PEEP titration

  • Active comparator
    Cdyn-GROUP

    Cdyn-guided PEEP titration procedure to achieve individually optimal level of PEEP

    Procedure: Cdyn-guided PEEP titration

Interventions

  • ProcedureEIT-guided PEEP titration

    During the PEEP titration procedure, PEEP will be decreased from 18 cmH2O by 2 cmH2O every 20 ventilatory cycles, until a final PEEP of 6 cmH2O. On each level of PEEP EIT parameters and Cdyn values will be recorded in both groups. In the EIT-GROUP optimal PEEP is considered as the intersect between the lower percentage of overdistension and collapse, based on the diagnostic tool of the EIT device.

  • ProcedureCdyn-guided PEEP titration

    During the PEEP titration procedure, PEEP will be decreased from 18 cmH2O by 2 cmH2O every 20 ventilatory cycles, until a final PEEP of 6 cmH2O. On each level of PEEP EIT parameters and Cdyn values will be recorded in both groups. In the Cdyn-GROUP optimal PEEP is considered as the PEEP value resulting the highest possible Cdyn measured by the ventilator.

06

What researchers measure

Primary outcomes

  1. Mechanical Power (MP)

    MP is calculated using a comprehensive formula for volume-controlled ventilator mode: MP = 0.098 x RR x TV (L) x \[ Ppeak - ½ x (Pplat - PEEP)\] (RR: respiratory rate TV: tidal volume Ppeak: airway peak pressure Pplat: plateau pressure PEEP: positive end-expiratory pressure)

    Time frame: During surgery

Secondary outcomes

  1. Oxygenation

    Oxygenation indicated by the PaO2/FiO2 ratio

    Time frame: From the beginning of surgery to 48 hours after surgery

  2. Positive end-expiratory pressure (PEEP)

    The level of individually optimal PEEP determined during a PEEP titration procedure

    Time frame: During surgery

  3. Dynamic pulmonary compliance (Cdyn)

    Dynamic pulmonary compliance measured by the ventilator during mechanical ventilation

    Time frame: During surgery

  4. Driving pressure (dP)

    Driving pressure - as an important safety limit of mechanical ventilation - is calculated using a formula: dP = Pplat - PEEP (Pplat: plateau pressure, PEEP: positive end-expiratory pressure)

    Time frame: During surgery

  5. Postoperative Pulmonary Complications (PPCs)

    PPCs are defined as: 1. atelectasis detected on computed tomography or chest radiograph, 2. pneumonia, 3. Acute Respiratory Distress Syndrome, 4. pulmonary aspiration (clear clinical history AND radiological evidence) within 48 hours after surgery

    Time frame: From the end of surgery to 48 hours

Other outcomes

  1. Length of hospital stay

    Length of hospital stay in days after surgery

    Time frame: From the date of surgery until discharge, up to 28 days

  2. In-hospital mortality

    Death occured during hospital stay after surgery

    Time frame: From date of surgery until the date of death, up to 28 days

  3. 28-days mortality

    Death occured during 28 days after surgery

    Time frame: 28 days after surgery

  4. Adverse events related to the PEEP titrating procedure

    Adverse Events (AEs) related to the PEEP titrating procedure are defined as: severe or prolonged hypotension (systolic blood pressure \< 90 mmHg); significant cardiac arrhythmias Serious adverse events (SAEs) related to the PEEP titrating procedure are defined as: severe barotrauma leading to pneumothorax; significant prolongation of hospitalization; persistent or significant disability or incapacity; severe deterioration (life-threatening state or even death)

    Time frame: During surgery

07

Study locations

1 of 3 sites recruiting
  • Semmelweis University
    Budapest, Budapest 1085, Hungary
    • Zsolt Molnár, MD, PhD · Contact · molnar.zsolt1@semmelweis.hu · +36 30 302 6668
    • Zsolt Molnár, MD, PhD · Principal investigator
    • Csenge Szigetváry, MD · Sub investigator
    Not yet recruiting
  • Semmelweis Hospital Kiskunhalas
    Kiskunhalas, Bács-Kiskun county 6400, Hungary
    • András Lovas, MD, PhD · Contact · anlovas@gmail.com · +36 20 465 8580
    • András Lovas, MD, PhD · Principal investigator
    • Robin Forgács, MD · Sub investigator
    Not yet recruiting
  • Flór Ferenc Hospital Kistarcsa
    Kistarcsa, Pest County 2143, Hungary
    • Zoltán Ruszkai, MD, PhD · Contact · ruszkai.zoltan@florhosp.hu · +36 20 915 1978
    • Gergely Bokrétás, MD · Contact · bokretas.gergely@florhosp.hu
    • Zoltán Ruszkai, MD, PhD · Principal investigator
    • Csanád Geréd, MD · Sub investigator
    • Angéla Mikó, MD · Sub investigator
    • Gergely Bokrétás, MD · Sub investigator
    • Tamás Fekete, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • Gered C, Szigetvary C, Miko A, Bokretas GP, Lovas A, Forgacs R, Nemes M, Molnar Z, Ruszkai Z. ElecTrical Impedance TomogRaphy vs dynamic compliANce guided positive end-expiratory pressure Titration during laparoscopic gynaecological surgery (TITRANT): protocol for a multicentre randomised trial. BMJ Open. 2026 Jun 17;16(6):e117631. doi: 10.1136/bmjopen-2026-117631. PubMed 42309662 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 12, 2025
  • Informed consent form · Mar 12, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07170514
Lead sponsor
Pest County Flór Ferenc Hospital
Collaborators
Kiskunhalas Semmelweis Hospital the Teaching Hospital of the University of Szeged, Semmelweis University
Responsible party
Zoltan Ruszkai, MD, PhD (Head of Department of Anesthesiology and Intensive Therapy, Pest County Flór Ferenc Hospital) — Principal investigator
First posted
Sep 12, 2025
Start date
Nov 10, 2025
Primary completion
Sep 30, 2027 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Apr 14, 2026

Study contacts

Zoltán Ruszkai, MD, PhD
Contact
ruszkai.zoltan@florhosp.hu
36-20-915-1978
Gergely Bokrétás, MD
Contact
bokretas.gregely@florhosp.hu
Zoltán Ruszkai, MD, PhD
study director · Flór Ferenc Hospital Kistarcsa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion